News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
For children, yes, the CDC’s “shared decision-making” guidance preserves the status quo in which Medicaid and U.S.
Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect a high-risk family member are scared.
The Trump administration has moved to end funding for a broad swath of HIV vaccine research, saying current approaches are ...
Uncertainty now dominates the COVID vaccine outlook after official recommendations were stripped for a variety of groups.
The CDC is urging Americans to make sure they’re protected against measles before traveling to other countries this summer.
As promised, federal health officials this week dropped longstanding recommendations that healthy children and healthy ...
The US Centers for Disease Control and Prevention has updated its immunization schedule for children, days after US Health ...
A team of US researchers has developed a new type of mRNA vaccine that is more scalable and adaptable to tackle continuously ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback